Evidence map›Paper›PMID 30158299›Full record

ReviewClinical microbiology reviews2018

Epidemiology, Biology, and Impact of Clonal Pseudomonas aeruginosa Infections in Cystic Fibrosis.

Michael D Parkins, Ranjani Somayaji, Valerie J Waters

Abstract readReview
In one paragraph

Review in Clinical microbiology reviews, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 136 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
136citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

136 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Stenotrophomonas maltophilia in people with Cystic Fibrosis: a systematic review of prevalence, risk factors and management.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2023
    Pooled it
  2. Long-term amikacin liposome inhalation suspension in cystic fibrosis patients with chronic P. aeruginosa infection.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2021
    Trial
  3. Global epidemiology of carbapenem-resistantJAC-antimicrobial resistance · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Phage-Mediated Iron Acquisition bybioRxiv : the preprint server for biology · 2026
    Article
  10. Article
  11. Article
  12. The fatty acid synthesis geneMicrobiology spectrum · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Resistance ofAntibiotics (Basel, Switzerland) · 2025
    Article
  19. Article
  20. High-riskHeliyon · 2025
    Article

76 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Michael D ParkinsDepartment of Medicine, University of Calgary, Calgary, Alberta, Canada mdparkin@ucalgary.ca.
Ranjani SomayajiDepartment of Medicine, University of Calgary, Calgary, Alberta, Canada.
Valerie J WatersTranslational Medicine, Research Institute, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic lower airway infection with

Indexed as

Clone CellsCystic FibrosisHumansPrognosisPseudomonas aeruginosaPseudomonas Infectionsbronchiectasisclone Ccystic fibrosisepidemic strainsgenotypinginfection controlLiverpool epidemic strainPseudomonas aeruginosashared strainsstrain typingtransmissible strain

Identifiers

PMID30158299
PMCPMC6148191

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.